Latest posts 5
$NEU
NEU FDA grants Orphan Drug Designation for NNZ-2591 to treat HIE
neurenpharma.com/announcements/…
NEU FDA grants Orphan Drug Designation for NNZ-2591 to treat HIE
neurenpharma.com/announcements/…
neurenpharma.com ASX:NEU - FDA grants Orphan Drug Designation for NNZ-2591 to treat HIE Read and interact with this announcement: FDA grants Orphan Drug Designation for NNZ-2591 to treat HIE on Neuren Pharmaceuticals's investor hub $DTIL
Precision BioSciences to Report Third Quarter 2026 Financial Results on November 3, 2026
investor.precisionbiosciences.com/news-releases/…
investor.precisionbiosciences.com Precision BioSciences to Report Third Quarter 2026 Financial Results on November 3, 2026 | Precis... DURHAM, N.C. --(BUSINESS WIRE)--Oct. 29, 2026-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo... Precision BioSciences to Report Third Quarter 2026 Financial Results on November 3, 2026
investor.precisionbiosciences.com/news-releases/…
$TGTX TG Therapeutics Announces Phase 1 Data Evaluating Azer-cel in Progressive Multiple Sclerosis in a Late-Breaking Oral Presentation at MSToronto2026 | TG Therapeutics, Inc. ir.tgtherapeutics.com/news-releases/…View quoted post on X
